Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma

Clinical trial NCT05723991 · UNKNOWN

Trial details

NCT number: NCT05723991
Sponsor: Chunguang yang (101937)
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Radical Cystectomy Urothelial Carcinoma

Start date: 2022-09-28
Primary completion: 2024-09-28
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.